TriangleImplantable Microdevice (NCT05700461)
Implantable Microdevice trial for Metastatic Renal Cell Carcinoma (NCT05700461). This is a short film with English narration. The transcript is on this page, and the written brief is separate.
What the film says
Read the transcript
This trial is for adults with kidney cancer that has spread, who are having surgery to remove a tumor.
The idea: before surgery, a tiny device is placed into the tumor through a needle. It has twenty small reservoirs that release very small doses of standard cancer drugs and combinations. When the tumor is removed, the tissue around each reservoir shows how the cancer responded to each drug.
The study looks at whether placing and retrieving the device is safe and feasible.
This phase 1 study plans 20 patients. At Dana-Farber Cancer Institute in Boston, Wenxin Xu leads it.
Public record; not medical advice.
Already in a trial?
It turns into a project to manage: visits, scans, labs, side effects and paperwork. Triangle keeps it organized in one place for you or for whoever's helping.
Organize my trial7-day free trial, then $9 a month. Cancel anytime.
How these trials work: what Phase 1 actually is · common questions Not clinical evidence.